Premium
Phase I/II study of high dose pomalidomide with G‐CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma
Author(s) -
Manasanch Elisabet E.,
Jain Preetesh,
Chen Wendy,
Oriabure Onyeka,
Badillo Maria,
Feng Lei,
Berkova Zuzana,
Orlowski Robert Z.,
Wang Michael
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25858
Subject(s) - pomalidomide , medicine , dexamethasone , neutropenia , multiple myeloma , refractory (planetary science) , lenalidomide , granulocyte colony stimulating factor , phases of clinical research , gastroenterology , absolute neutrophil count , febrile neutropenia , toxicity , chemotherapy , astrobiology , physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom